表紙:血液疾患治療薬の世界市場:2030年までの機会と戦略:COVID-19の中での影響と回復
市場調査レポート
商品コード
1057071

血液疾患治療薬の世界市場:2030年までの機会と戦略:COVID-19の中での影響と回復

Hematology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

出版日: | 発行: The Business Research Company | ページ情報: 英文 353 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
血液疾患治療薬の世界市場:2030年までの機会と戦略:COVID-19の中での影響と回復
出版日: 2022年02月01日
発行: The Business Research Company
ページ情報: 英文 353 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の血液疾患治療薬市場について調査分析し、市場の特徴、市場の動向と戦略、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 血液疾患治療薬市場のエグゼクティブサマリー

第2章 目次

第3章 図のリスト

第4章 表のリスト

第5章 レポートの構造

第6章 イントロダクション

  • セグメンテーション:地域別
  • セグメンテーション:タイプ別
  • セグメンテーション:流通チャネル別
  • セグメンテーション:投与経路別
  • セグメンテーション:薬剤分類別
  • セグメンテーション:購入モード別

第7章 血液疾患治療薬市場の特徴

  • 市場の定義
  • セグメンテーション:タイプ別
    • 血友病
    • 血液製剤
    • 貧血
    • その他の造血系疾患薬
  • セグメンテーション:流通チャネル別
    • 病院薬局
    • 小売薬局/ドラッグストア
    • その他
  • セグメンテーション:投与経路別
    • 経口
    • 非経口
  • セグメンテーション:薬剤分類別
    • ブランド薬
    • ジェネリック薬剤
  • セグメンテーション:購入モード別
    • 市販薬
    • 処方薬

第8章 血液疾患治療薬市場、製品/サービス分析-製品/サービスの例

第9章 血液疾患治療薬市場、サプライチェーン分析

  • サプライチェーン
    • 原材料サプライヤー
    • 受託研究機関(CRO)
    • 血液疾患治療薬メーカー
    • 受託製造機関(CMO)
  • 流通
    • 卸売業者/販売業者
    • 小売業者(薬局)および病院
    • 血液専門医
  • エンドユーザー

第10章 血液疾患治療薬市場の顧客情報

  • 欧州における血友病患者の課題と懸念
  • インドの子供と女性の貧血の増加
  • 鎌状赤血球症の経済への影響

第11章 血液疾患治療薬市場の動向と戦略

  • 薬剤開発のためのバイオマーカーの使用
  • 点滴センターにおける鎌状赤血球症の疼痛管理
    • 3Dプリンティング技術
  • 血液学における人工知能(AI)
  • 希少疾患における遠隔医療サポート

第12章 血液疾患治療薬市場に対するCOVID-19の影響

  • 臨床試験の遅れ
  • サプライチェーンの問題
  • COVID-19および血液の異常
  • 今後の展望

第13章 世界の血液疾患治療薬の市場規模と成長

  • 市場規模
  • 市場成長実績、金額(100万米ドル)(2015年~2020年)
    • 市場成長要因(2015年~2020年)
    • 市場抑制要因(2015年~2020年)
  • 予測市場成長、金額(100万米ドル)(2020年~2025年)(2030年)
    • 市場成長要因(2020年~2025年)
    • 市場抑制要因(2020年~2025年)

第14章 血液疾患治療薬市場、地域分析

  • 世界の血液疾患治療薬市場、実績および予測、金額(100万米ドル)(2015年~2020年)(2025年)(2030年):地域別
  • 世界の血液疾患治療薬市場、実績および予測(2015年~2025年):地域別
  • 世界の血液疾患治療薬市場、成長と市場シェアの比較(2020年~2025年):地域別

第15章 世界の血液疾患治療薬市場のセグメンテーション

  • 世界の血液疾患治療薬市場、実績および予測、金額(100万米ドル)(2015年~2020年)(2025年)(2030年):タイプ別
    • 血友病
    • 貧血
    • その他
    • 血液製剤
  • 世界の血液疾患治療薬市場、実績および予測、金額(100万米ドル)(2015年~2020年)(2025年)(2030年):流通チャネル別
  • 世界の血液疾患治療薬市場、実績および予測、金額(100万米ドル)(2015年~2020年)(2025年)(2030年):投与経路別
  • 世界の血液疾患治療薬市場、実績および予測、金額(100万米ドル)(2015年~2020年)(2025年)(2030年):薬剤分類別
    • ブランド
    • ジェネリック
  • 世界の血液疾患治療薬市場、実績および予測、金額(100万米ドル)(2015年~2020年)(2025年)(2030年):購入モード別
    • 処方薬
    • 市販薬

第16章 世界の血液疾患治療薬市場の指標

  • 血液疾患治療薬の市場規模、GDPの割合、世界
  • 一人当たりの平均血液疾患治療薬市場支出、世界

第17章 アジア太平洋の血液疾患治療薬市場

第18章 西欧の血液疾患治療薬市場

第19章 東欧の血液疾患治療薬市場

第20章 北米の血液疾患治療薬市場

第21章 南米の血液疾患治療薬市場

第22章 中東の血液疾患治療薬市場

第23章 アフリカの血液疾患治療薬市場

第24章 世界の血液疾患治療薬市場の競合情勢

  • 企業プロファイル
  • Takeda Pharmaceutical Company
    • 企業概要
    • 製品およびサービス
    • 事業戦略
    • 財務概要
  • Roche Holding AG
    • 企業概要
    • 製品およびサービス
    • 事業戦略
    • 財務概要
  • Amgen Inc.
    • 企業概要
    • 製品およびサービス
    • 事業戦略
    • 財務概要
  • Novartis AG
    • 企業概要
    • 製品およびサービス
    • 事業戦略
    • 財務概要
  • Novo Nordisk A/S
    • 企業概要
    • 製品およびサービス
    • 事業戦略
    • 財務概要

第25章 血液疾患治療薬市場における主要な合併と買収

  • PfizerがTrillium Therapeuticsを買収
  • MorphosysがConstellation Pharmaceuticalsを買収
  • Jazz PharmaceuticalsがGW Pharmaceuticals plcを買収
  • BayerがAskBio Biopharmaceuticalを買収
  • AbbVieがAllergan plcを買収
  • SobiがDova Pharmaceuticalsを買収
  • Hoffmann-La Roche Ltd.がSpark Therapeuticsを買収
  • AbbVieがPharmacyclicsを買収

第26章 市場の背景:薬剤市場

  • 薬剤市場の特徴
    • 市場の定義
    • セグメンテーション:タイプ別
  • 世界の薬剤市場、実績および予測、金額(100万米ドル)(2015年~2020年)(2025年):タイプ別(2030年)
    • 代謝障害薬
    • 抗感染症薬
    • 中枢神経系薬
    • 呼吸器疾患薬
    • 心血管薬
    • 筋骨格系障害薬
    • 腫瘍薬
    • 血液薬
    • 泌尿生殖器薬
    • 胃腸薬
    • 皮膚薬
    • 眼科薬
  • 世界の薬剤市場、実績および予測、金額(100万米ドル)(2015年~2020年)(2025年)(2030年):地域別

第27章 血液疾患治療薬市場の将来展望と潜在的分析

  • 世界の血液疾患治療薬市場-最も新しい機会を提供している国(2025年)
  • 世界の血液疾患治療薬市場-最も新しい機会を提供するセグメント(2025年)
  • 世界の血液疾患治療薬市場-成長戦略(2025年)
    • 市場動向ベースの戦略
    • 競合戦略

第28章 血液疾患治療薬市場、結論・提言

  • 結論
  • 推奨事項
    • 製品
    • 場所
    • 価格
    • プロモーション

第29章 付録

目次
Product Code: o&s366

“Hematology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery” from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global hematology drugs market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 48+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Where is the largest and fastest growing market for hematology drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? “The hematology drugs market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider hematology drugs market; and compares it with other markets.

The report covers the following chapters:

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, segmentation by distribution channel, segmentation by route of administration, segmentation by drug classification, segmentation by mode of purchase.
  • Market Characteristics - The market characteristics section of the report defines and explains the hematology drugs market. This chapter also defines and describes goods and related services covered in the report.
  • Supply Chain - The supply chain section of the report defines and explains the key players in the hematology drugs industry supply chain.
  • Product Analysis - The product analysis section of the report describes the leading products in the hematology drugs market along with key features and differentiators for those products.
  • Customer Information - This chapter covers recent customers' trends/preferences in the global hematology drugs market.
  • Trends And Strategies - This chapter describes the major trends shaping the global hematology drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • COVID Impact - This chapter describes the COVID impact on the global hematology drugs industry.
  • Global Market Size And Growth - This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
  • Global Macro Comparison - The global hematology drugs market comparison with macro-economic factors gives the hematology drugs market size, percentage of GDP, and average hematology drugs market expenditure.
  • Regional Market Size and Growth - This section contains the region's market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global hematology drugs market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Background - This section describes the pharmaceutical drugs market of which the hematology drugs market is a segment. This chapter includes the global pharmaceutical drugs market 2015-20 and 2020-25 values, and regional and country analyses for the pharmaceutical drugs market.
  • Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for hematology drugs companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

  • 1) By Type: Hemophilia; Blood Products; Anemia; Other Blood Disorder Drugs
  • 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Others
  • 3) By Route Of Administration: Oral; Parenteral; Others
  • 4) By Drug Classification: Branded Drugs; Generic Drugs
  • 5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
  • Companies Mentioned: Takeda Pharmaceutical Company; Roche Holding AG; Amgen Inc.; Novartis AG; Novo Nordisk A/S
  • Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; hematology drugs indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Hematology Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

  • 6.1. Segmentation By Geography
  • 6.2. Segmentation By Type
  • 6.3. Segmentation By Distribution Channel
  • 6.4. Segmentation By Route Of Administration
  • 6.5. Segmentation By Drug Classification
  • 6.6. Segmentation By Mode Of Purchase

7. Hematology Drugs Market Characteristics

  • 7.1. Market Definition
  • 7.2. Segmentation By Type
    • 7.2.1. Hemophilia
    • 7.2.2. Blood Products
    • 7.2.3. Anemia
    • 7.2.4. Other Blood Disorder Drugs
  • 7.3. Segmentation By Distribution Channel
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies/ Drug Stores
    • 7.3.3. Others
  • 7.4. Segmentation By Route Of Administration
    • 7.4.1. Oral
    • 7.4.2. Parenteral
  • 7.5. Segmentation By Drug Classification
    • 7.5.1. Branded Drugs
    • 7.5.2. Generic Drugs
  • 7.6. Segmentation By Mode Of Purchase
    • 7.6.1. Over The Counter Drugs
    • 7.6.2. Prescription-Based Drugs

8. Hematology Drugs Market, Product/Service Analysis - Product/Service Examples

9. Hematology Drugs Market, Supply Chain Analysis

  • 9.1. Supply Chain
    • 9.1.1. Raw Material Suppliers
    • 9.1.2. Contract Research Organization (CRO)
    • 9.1.3. Hematology Drugs Manufacturer
    • 9.1.4. Contract Manufacturing Organization (CMO)
  • 9.2. Distribution
    • 9.2.1. Wholesalers/Distributors
    • 9.2.2. Retailers (Pharmacies) And Hospitals
    • 9.2.3. Hematologists
  • 9.3. End-Users

10. Hematology Drugs Market Customer Information

  • 10.1. Hemophilia Patients Challenges And Concerns in Europe
  • 10.2. Rise in Anemia in Children and Women in India
  • 10.3. Sickel Cell Disease Impact On Economy

11. Hematology Drugs Market Trends And Strategies

  • 11.1. Use of Biomarkers for Drug Development
  • 11.2. Sickle Cell Disease Pain Management In Infusion Centers
    • 11.3. 3D Printing Technology
  • 11.4. Artificial Intelligence (AI) In Hematology
  • 11.5. Telemedicine Support in Rare Disease

12. Impact Of COVID-19 On The Hematology Drugs Market

  • 12.1. Clinical Trial Delays
  • 12.2. Supply Chain Issues
  • 12.3. COVID-19 And Hematological Abnormalities
  • 12.4. Future Outlook

13. Global Hematology Drugs Market Size And Growth

  • 13.1. Market Size
  • 13.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
    • 13.2.1. Drivers Of The Market 2015 - 2020
    • 13.2.2. Restraints On The Market 2015 - 2020
  • 13.3. Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
    • 13.3.1. Drivers Of The Market 2020 - 2025
    • 13.3.2. Restraints On The Market 2020 - 2025

14. Hematology Drugs Market, Regional Analysis

  • 14.1. Global Hematology Drugs Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.2. Global Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Region
  • 14.3. Global Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Region

15. Global Hematology Drugs Market Segmentation

  • 15.1. Global Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 15.1.1. Hemophilia
    • 15.1.2. Anemia
    • 15.1.3. Others
    • 15.1.4. Blood Products
  • 15.2. Global Hematology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 15.3. Global Hematology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 15.4. Global Hematology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 15.4.1. Branded
    • 15.4.2. Generic
  • 15.5. Global Hematology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 15.5.1. Prescription
    • 15.5.2. OTC

16. Global Hematology Drugs Market Metrics

  • 16.1. Hematology Drugs Market Size, Percentage Of GDP, Global
  • 16.2. Per Capita Average Hematology Drugs Market Expenditure, Global

17. Asia-Pacific Hematology Drugs Market

  • 17.1. Asia-Pacific Hematology Drugs Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Market Information
    • 17.1.3. Background Information
    • 17.1.4. Government Initiatives
    • 17.1.5. Regulations
    • 17.1.6. Regulatory Bodies
    • 17.1.7. Major Associations
    • 17.1.8. Taxes Levied
    • 17.1.9. Corporate Tax Structure
    • 17.1.10. Investments
    • 17.1.11. Major Companies
  • 17.2. Asia-Pacific Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.3. Asia-Pacific Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.4. Asia-Pacific Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.5. Asia-Pacific Hematology Drugs Market, 2020, By Country, Value ($ Million)
  • 17.6. Asia-Pacific Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 17.7. Asia-Pacific Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 17.8. Asia-Pacific Hematology Drugs Market: Country Analysis
  • 17.9. Australia Hematology Drugs Market
  • 17.10. Australia Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.11. Australia Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.12. Australia Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.13. China Hematology Drugs Market
  • 17.14. China Hematology Drugs Market Overview
    • 17.14.1. Country Information
    • 17.14.2. Market Information
    • 17.14.3. Background Information
    • 17.14.4. Government Initiatives
    • 17.14.5. Regulations
    • 17.14.6. Regulatory Bodies
    • 17.14.7. Major Associations
    • 17.14.8. Taxes Levied
    • 17.14.9. Corporate Tax Structure
    • 17.14.10. Investments
    • 17.14.11. Major Companies
  • 17.15. China Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.16. China Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.17. China Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.18. Hong Kong Hematology Drugs Market
  • 17.19. Hong Kong Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.20. Hong Kong Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.21. India Hematology Drugs Market
  • 17.22. India Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.23. India Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.24. India Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.25. Indonesia Hematology Drugs Market
  • 17.26. Indonesia Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.27. Indonesia Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.28. Indonesia Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.29. Japan Hematology Drugs Market
  • 17.30. Japan Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.31. Japan Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.32. Japan Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.33. Malaysia Hematology Drugs Market
  • 17.34. Malaysia Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.35. Malaysia Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.36. New Zealand Hematology Drugs Market
  • 17.37. New Zealand Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.38. New Zealand Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.39. Philippines Hematology Drugs Market
  • 17.40. Philippines Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.41. Philippines Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.42. Singapore Hematology Drugs Market
  • 17.43. Singapore Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.44. Singapore Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.45. South Korea Hematology Drugs Market
  • 17.46. South Korea Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.47. South Korea Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.48. South Korea Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.49. Thailand Hematology Drugs Market
  • 17.50. Thailand Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.51. Thailand Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.52. Vietnam Hematology Drugs Market
  • 17.53. Vietnam Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.54. Vietnam Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)

18. Western Europe Hematology Drugs Market

  • 18.1. Western Europe Hematology Drugs Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Market Information
    • 18.1.3. Background Information
    • 18.1.4. Government Initiatives
    • 18.1.5. Regulations
    • 18.1.6. Regulatory Bodies
    • 18.1.7. Major Associations
    • 18.1.8. Taxes Levied
    • 18.1.9. Corporate Tax Structure
    • 18.1.10. Investments
    • 18.1.11. Major Companies
  • 18.2. Western Europe Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.3. Western Europe Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.4. Western Europe Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.5. Western Europe Hematology Drugs Market, 2020, By Country, Value ($ Million)
  • 18.6. Western Europe Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 18.7. Western Europe Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 18.8. Western Europe Hematology Drugs Market: Country Analysis
  • 18.9. Austria Hematology Drugs Market
  • 18.10. Austria Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.11. Austria Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.12. Belgium Hematology Drugs Market
  • 18.13. Belgium Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.14. Belgium Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.15. Denmark Hematology Drugs Market
  • 18.16. Denmark Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.17. Denmark Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.18. Finland Hematology Drugs Market
  • 18.19. Finland Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.20. Finland Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.21. France Hematology Drugs Market
  • 18.22. France Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.23. France Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.24. France Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.25. Germany Hematology Drugs Market
  • 18.26. Germany Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.27. Germany Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.28. Germany Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.29. Ireland Hematology Drugs Market
  • 18.30. Ireland Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.31. Ireland Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.32. Italy Hematology Drugs Market
  • 18.33. Italy Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.34. Italy Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.35. Netherlands Hematology Drugs Market
  • 18.36. Netherlands Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.37. Netherlands Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.38. Norway Hematology Drugs Market
  • 18.39. Norway Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.40. Norway Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.41. Portugal Hematology Drugs Market
  • 18.42. Portugal Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.43. Portugal Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.44. Spain Hematology Drugs Market
  • 18.45. Spain Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.46. Spain Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.47. Sweden Hematology Drugs Market
  • 18.48. Sweden Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.49. Sweden Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.50. Switzerland Hematology Drugs Market
  • 18.51. Switzerland Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.52. Switzerland Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.53. UK Hematology Drugs Market
  • 18.54. UK Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.55. UK Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.56. UK Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Eastern Europe Hematology Drugs Market

  • 19.1. Eastern Europe Hematology Drugs Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. Background Information
    • 19.1.4. Government Initiatives
    • 19.1.5. Regulations
    • 19.1.6. Regulatory Bodies
    • 19.1.7. Major Associations
    • 19.1.8. Taxes Levied
    • 19.1.9. Corporate Tax Structure
    • 19.1.10. Investments
    • 19.1.11. Major Companies
  • 19.2. Eastern Europe Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.3. Eastern Europe Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.4. Eastern Europe Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.5. Eastern Europe Hematology Drugs Market, 2020, By Country, Value ($ Million)
  • 19.6. Eastern Europe Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 19.7. Eastern Europe Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 19.8. Eastern Europe Hematology Drugs Market: Country Analysis
  • 19.9. Czech Republic Hematology Drugs Market
  • 19.10. Czech Republic Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.11. Czech Republic Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.12. Poland Hematology Drugs Market
  • 19.13. Poland Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.14. Poland Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.15. Romania Hematology Drugs Market
  • 19.16. Romania Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.17. Romania Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.18. Russia Hematology Drugs Market
  • 19.19. Russia Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.20. Russia Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.21. Russia Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

20. North America Hematology Drugs Market

  • 20.1. North America Hematology Drugs Market Overview
    • 20.1.1. Region Information
    • 20.1.2. Market Information
    • 20.1.3. Background Information
    • 20.1.4. Government Initiatives
    • 20.1.5. Regulations
    • 20.1.6. Regulatory Bodies
    • 20.1.7. Associations
    • 20.1.8. Taxes Levied
    • 20.1.9. Corporate Tax Structure
    • 20.1.10. Investments
    • 20.1.11. Major players
  • 20.2. North America Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Billion)
  • 20.3. North America Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Billion)
  • 20.4. North America Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Billion)
  • 20.5. North America Hematology Drugs Market, 2020, By Country, Value ($ Billion)
  • 20.6. North America Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 20.7. North America Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 20.8. North America Hematology Drugs Market: Country Analysis
  • 20.9. Canada Hematology Drugs Market
  • 20.10. Canada Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Billion)
  • 20.11. Canada Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Billion)
  • 20.12. Mexico Hematology Drugs Market
  • 20.13. Mexico Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Billion)
  • 20.14. Mexico Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Billion)
  • 20.15. USA Hematology Drugs Market
  • 20.16. USA Hematology Drugs Market Overview
    • 20.16.1. Country Information
    • 20.16.2. Market Information
    • 20.16.3. Background Information
    • 20.16.4. Government Initiatives
    • 20.16.5. Regulations
    • 20.16.6. Regulatory Bodies
    • 20.16.7. Major Associations
    • 20.16.8. Taxes Levied
    • 20.16.9. Corporate Tax Structure
    • 20.16.10. Investments
    • 20.16.11. Major players
  • 20.17. USA Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Billion)
  • 20.18. USA Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Billion)
  • 20.19. USA Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Billion)

21. South America Hematology Drugs Market

  • 21.1. South America Hematology Drugs Market Overview
    • 21.1.1. Region Information
    • 21.1.2. Market Information
    • 21.1.3. Background Information
    • 21.1.4. Regulations
    • 21.1.5. Regulatory Bodies
    • 21.1.6. Major Associations
    • 21.1.7. Taxes Levied
    • 21.1.8. Corporate Tax Structure
    • 21.1.9. Investments
    • 21.1.10. Major Companies
  • 21.2. South America Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.3. South America Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.4. South America Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 21.5. South America Hematology Drugs Market, 2020, By Country, Value ($ Million)
  • 21.6. South America Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 21.7. South America Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 21.8. South America Hematology Drugs Market: Country Analysis
  • 21.9. Argentina Hematology Drugs Market
  • 21.10. Argentina Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.11. Argentina Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.12. Brazil Hematology Drugs Market
  • 21.13. Brazil Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.14. Brazil Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.15. Brazil Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 21.16. Chile Hematology Drugs Market
  • 21.17. Chile Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.18. Chile Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.19. Colombia Hematology Drugs Market
  • 21.20. Colombia Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.21. Colombia Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.22. Peru Hematology Drugs Market
  • 21.23. Peru Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.24. Peru Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.25. Venezuela Hematology Drugs Market
  • 21.26. Venezuela Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.27. Venezuela Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)

22. Middle East Hematology Drugs Market

  • 22.1. Middle East Hematology Drugs Market Overview
    • 22.1.1. Region Information
    • 22.1.2. Market Information
    • 22.1.3. Background Information
    • 22.1.4. Government Initiatives
    • 22.1.5. Regulations
    • 22.1.6. Regulatory Bodies
    • 22.1.7. Major Associations
    • 22.1.8. Taxes Levied
    • 22.1.9. Corporate Tax Structure
    • 22.1.10. Investments
    • 22.1.11. Major Companies
  • 22.2. Middle East Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 22.3. Middle East Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 22.4. Middle East Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 22.5. Middle East Hematology Drugs Market, 2020, By Country, Value ($ Million)
  • 22.6. Middle East Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 22.7. Middle East Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 22.8. Middle East Hematology Drugs Market: Country Analysis
  • 22.9. Israel Hematology Drugs Market
  • 22.10. Israel Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 22.11. Israel Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 22.12. Saudi Arabia Hematology Drugs Market
  • 22.13. Saudi Arabia Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 22.14. Saudi Arabia Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 22.15. Turkey Hematology Drugs Market
  • 22.16. Turkey Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 22.17. Turkey Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 22.18. UAE Hematology Drugs Market
  • 22.19. UAE Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 22.20. UAE Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)

23. Africa Hematology Drugs Market

  • 23.1. Africa Hematology Drugs Market Overview
    • 23.1.1. Region Information
    • 23.1.2. Market Information
    • 23.1.3. Background information
    • 23.1.4. Government Initiatives
    • 23.1.5. Regulations
    • 23.1.6. Regulatory Bodies
    • 23.1.7. Major Associations
    • 23.1.8. Taxes Levied
    • 23.1.9. Corporate Tax Structure
    • 23.1.10. Investments
    • 23.1.11. Major Companies
  • 23.2. Africa Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 23.3. Africa Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 23.4. Africa Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 23.5. Africa Hematology Drugs Market, 2020, By Country, Value ($ Million)
  • 23.6. Africa Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 23.7. Africa Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 23.8. Africa Hematology Drugs Market: Country Analysis
  • 23.9. Egypt Hematology Drugs Market
  • 23.10. Egypt Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 23.11. Egypt Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 23.12. Nigeria Hematology Drugs Market
  • 23.13. Nigeria Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 23.14. Nigeria Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 23.15. South Africa Hematology Drugs Market
  • 23.16. South Africa Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 23.17. South Africa Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)

24. Hematology Drugs Global Market Competitive Landscape

  • 24.1. Company Profiles
  • 24.2. Takeda Pharmaceutical Company
    • 24.2.1. Company Overview
    • 24.2.2. Products And Services
    • 24.2.3. Business Strategy
    • 24.2.4. Financial Overview
  • 24.3. Roche Holding AG
    • 24.3.1. Company Overview
    • 24.3.2. Products And Services
    • 24.3.3. Business Strategy
    • 24.3.4. Financial Overview
  • 24.4. Amgen Inc.
    • 24.4.1. Company Overview
    • 24.4.2. Products And Services
    • 24.4.3. Business Strategy
    • 24.4.4. Financial Overview
  • 24.5. Novartis AG
    • 24.5.1. Company Overview
    • 24.5.2. Products And Services
    • 24.5.3. Business Strategy
    • 24.5.4. Financial Overview
  • 24.6. Novo Nordisk A/S
    • 24.6.1. Company Overview
    • 24.6.2. Products And Services
    • 24.6.3. Business Strategy
    • 24.6.4. Financial Overview

25. Key Mergers And Acquisitions In The Hematology Drugs Market

  • 25.1. Pfizer Acquired Trillium Therapeutics
  • 25.2. Morphosys Acquired Constellation Pharmaceuticals
  • 25.3. Jazz Pharmaceuticals Acquired GW Pharmaceuticals plc
  • 25.4. Bayer Acquired AskBio Biopharmaceutical
  • 25.5. AbbVie Acquired Allergan plc
  • 25.6. Sobi Acquired Dova Pharmaceuticals
  • 25.7. Hoffmann-La Roche Ltd. Acquired Spark Therapeutics
  • 25.8. AbbVie Acquired Pharmacyclics

26. Market Background: Pharmaceutical Drugs Market

  • 26.1. Pharmaceutical Drugs Market Characteristics
    • 26.1.1. Market Definition
    • 26.1.2. Segmentation By Type
  • 26.2. Global Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 26.2.1. Metabolic Disorders Drugs
    • 26.2.2. Anti-Infective Drugs
    • 26.2.3. Central Nervous System Drugs
    • 26.2.4. Respiratory Diseases Drugs
    • 26.2.5. Cardiovascular Drugs
    • 26.2.6. Musculoskeletal Disorders Drugs
    • 26.2.7. Oncology Drugs
    • 26.2.8. Hematology Drugs
    • 26.2.9. Genito-Urinary Drugs
    • 26.2.10. Gastrointestinal Drugs
    • 26.2.11. Dermatology Drugs
    • 26.2.12. Ophthalmology Drugs
  • 26.3. Global Pharmaceutical Drugs Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

27. Hematology Drugs Market Future Outlook and Potential Analysis

  • 27.1. Global Hematology Drugs Market In 2025 - Countries Offering Most New Opportunities
  • 27.2. Global Hematology Drugs Market In 2025 - Segments Offering Most New Opportunities
  • 27.3. Global Hematology Drugs Market In 2025 - Growth Strategies
    • 27.3.1. Market Trend Based Strategies
    • 27.3.2. Competitor Strategies

28. Hematology Drugs Market, Conclusions And Recommendations

  • 28.1. Conclusions
  • 28.2. Recommendations
    • 28.2.1. Product
    • 28.2.2. Place
    • 28.2.3. Price
    • 28.2.4. Promotion
    • 28.2.5. People

29. Appendix

  • 29.1. Market Data Sources
  • 29.2. NAICS Definitions Of Industry Covered In This Report
  • 29.3. Research Methodology
  • 29.4. Currencies
  • 29.5. Research Inquiries
  • 29.6. The Business Research Company
  • 29.7. Copyright And Disclaimer